# Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis

> **NCT02242695** · PHASE4 · COMPLETED · sponsor: **Medinova AG** · enrollment: 150 (actual)

## Conditions studied

- Vulvovaginal Candidiasis

## Interventions

- **DRUG:** Fluomizin vaginal tablets
- **DRUG:** Canesten vaginal tablets

## Key facts

- **NCT ID:** NCT02242695
- **Lead sponsor:** Medinova AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-12
- **Final completion:** 2016-04
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2016-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02242695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02242695, "Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02242695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*